These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33522648)

  • 1. Transient characteristics of universal cells on human-induced pluripotent stem cells and their differentiated cells derived from foetal stem cells with mixed donor sources.
    Sung TC; Jiang YP; Hsu JY; Ling QD; Chen H; Kumar SS; Chang Y; Hsu ST; Ye Q; Higuchi A
    Cell Prolif; 2021 Mar; 54(3):e12995. PubMed ID: 33522648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of universal and hypoimmunogenic human pluripotent stem cells.
    Ye Q; Sung TC; Yang JM; Ling QD; He Y; Higuchi A
    Cell Prolif; 2020 Dec; 53(12):e12946. PubMed ID: 33174655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoimmunogenic human iPSCs expressing HLA-G, PD-L1, and PD-L2 evade innate and adaptive immunity.
    Tsuneyoshi N; Hosoya T; Takeno Y; Saitoh K; Murai H; Amimoto N; Tatsumi R; Watanabe S; Hasegawa Y; Kikkawa E; Goto K; Nishigaki F; Tamura K; Kimura H
    Stem Cell Res Ther; 2024 Jul; 15(1):193. PubMed ID: 38956724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
    Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
    Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Human Induced Pluripotent Stem Cells to Cardiomyocytes Using Embryoid Bodies.
    Hatani T; Miki K; Yoshida Y
    Methods Mol Biol; 2018; 1816():79-92. PubMed ID: 29987812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scalable Generation of Mesenchymal Stem Cells and Adipocytes from Human Pluripotent Stem Cells.
    Karam M; Younis I; Elareer NR; Nasser S; Abdelalim EM
    Cells; 2020 Mar; 9(3):. PubMed ID: 32183164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human induced pluripotent stem cells from two azoospermic patients with Klinefelter syndrome show similar X chromosome inactivation behavior to female pluripotent stem cells.
    Panula S; Kurek M; Kumar P; Albalushi H; Padrell Sánchez S; Damdimopoulou P; Olofsson JI; Hovatta O; Lanner F; Stukenborg JB
    Hum Reprod; 2019 Nov; 34(11):2297-2310. PubMed ID: 31743397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cells.
    Moon SH; Ban K; Kim C; Kim SS; Byun J; Song MK; Park IH; Yu SP; Yoon YS
    Int J Cardiol; 2013 Sep; 168(1):41-52. PubMed ID: 23044428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human amniotic mesenchymal stem cell-derived induced pluripotent stem cells may generate a universal source of cardiac cells.
    Ge X; Wang IN; Toma I; Sebastiano V; Liu J; Butte MJ; Reijo Pera RA; Yang PC
    Stem Cells Dev; 2012 Oct; 21(15):2798-808. PubMed ID: 22530853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity.
    Chen Y; Zhou Y; Zhou Z; Fang Y; Ma L; Zhang X; Xiong J; Liu L
    Stem Cell Res Ther; 2023 Jan; 14(1):11. PubMed ID: 36691086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the optimal suspension culture time for the osteoblastic differentiation of human induced pluripotent stem cells using the embryoid body method.
    Zhou P; Han Y; Shi J; Zhang R; Ren X; Li H; Lan F
    Biochem Biophys Res Commun; 2019 Aug; 515(4):586-592. PubMed ID: 31178132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
    Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
    Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome dynamics of human pluripotent stem cell-derived contracting cardiomyocytes using an embryoid body model with fetal bovine serum.
    Jung KB; Son YS; Lee H; Jung CR; Kim J; Son MY
    Mol Biosyst; 2017 Jul; 13(8):1565-1574. PubMed ID: 28671202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient generation of transgene- and feeder-free induced pluripotent stem cells from human dental mesenchymal stem cells and their chemically defined differentiation into cardiomyocytes.
    Tan X; Dai Q; Guo T; Xu J; Dai Q
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2490-2497. PubMed ID: 29217199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of small molecule-induced cardiomyocytes from human induced pluripotent stem cells using a reporter system.
    Hwang GH; Park SM; Han HJ; Kim JS; Yun SP; Ryu JM; Lee HJ; Chang W; Lee SJ; Choi JH; Choi JS; Lee MY
    J Cell Physiol; 2017 Dec; 232(12):3384-3395. PubMed ID: 28063225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Leukocyte Antigen Class I and II Knockout Human Induced Pluripotent Stem Cell-Derived Cells: Universal Donor for Cell Therapy.
    Mattapally S; Pawlik KM; Fast VG; Zumaquero E; Lund FE; Randall TD; Townes TM; Zhang J
    J Am Heart Assoc; 2018 Dec; 7(23):e010239. PubMed ID: 30488760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Leukocyte Antigen Class I Pseudo-Homozygous Mesenchymal Stem Cells Derived from Human Induced Pluripotent Stem Cells.
    Kwon D; Ahn HJ; Han MJ; Ji M; Ahn J; Seo KW; Kang KS
    Stem Cell Rev Rep; 2020 Aug; 16(4):792-808. PubMed ID: 32712868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of FluoVolt Membrane Potential Dye for Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Differentiated via Embryoid Bodies.
    Takaki T; Yoshida Y
    Methods Mol Biol; 2021; 2320():101-110. PubMed ID: 34302652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity.
    Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.